Lexington Biosciences Inc.
Lexington Biosciences, Inc. is a development stage medical device company operating within the healthcare industry. Lexington is focused on development and commercialization of non-invasive cardiovascular health monitoring products to allow predictive diagnosis of future cardiovascular events. The current focus of the company is to develop and market the HeartSentry endothelial function measurement product.
Lexington Biosciences Inc. (LNB)
Le 23 avril/April 2019
Lexington Biosciences, Inc., has announced a consolidation of its issued and outstanding share capital on the basis of one (1) post‐ consolidation share for each ten (10) pre‐consolidation common shares.
As a result, the outstanding shares of the company will be reduced to approximately 3,785,340 .
The shares will begin trading on a consolidated basis and with a new CUSIP number on April 24, 2019.
The name and symbol will not change.